You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Romania

Nov 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

The market grows in 2011, more in value than in volume

Compared with the previous year, the market grew in value with 12.4%, while compared with 2008 the market grew with around 50% reaching a value of around RON12 billion. However, compared with the same year (2008), the volume raised with only around 300 million units, mainly thanks to new launches and new types of medicines. The OTC sector raises in value to around RON3.9 billion, with a growth rate below the overall market, namely around 36%. Moreover, the OTC sector drops in volume since 2008 with 3.8%, possibly due to a decrease in the self medication practices.

Hospital expenses reach around 13% of the total market, while the retail covers the rest

The highest growth was for the hospital sector (around 40%) because the authorities decided to move various national health financed products, including the oncologic medicines, from the open retail sector to the hospital one, depriving the retail of a good chunk of value – RON1.42 billion in 2011, distribution prices. Moreover, the ‘parallel export’ represent a serious threat to the international producers and concomitantly depletes the market of local products which end up being exported instead of reaching the local market, due to the lower local prices compared with the international ones.

Expenses for health remain among slowest in Europe

The long-time economic crisis and the budgetary cuts had a powerful impact on this environment in terms of both public and of private expenses. Despite the fact that the decrease in public expenditure led to an increase in private spending (medicines and drugs that should be available in hospitals are absent and patients need to purchase them with their own money), per capita expenditure remains among the lowest in Europe. This is due to a set of circumstances, but mainly consumers’ attitude to illnesses: Romanians go to see a doctor only when experiencing serious illness, while prevention, regular checks and early treatments are uncommon. However, this indicates that there sound potential in this market.

Chemists and pharmacies lead distribution

Chemists/pharmacies continued to account for a large share of consumer healthcare sales in 2011, mainly boosted by the establishment of pharmacy chains, mostly owned and operated by the large drug distributors. The level of development, the standard and new look of pharmacy chains is very high. This trend is expected to continue over the forecast period, and more independent pharmacies are expected to join chains under franchise contract. Most of the market for medicines is regulated by the National Agency for Drugs, which also regulates distribution channels and allows most medicines to be sold through pharmacies only (unlike nutritional supplements, which can be sold anywhere).

Market has good growth potential

The consumer health market has very good growth potential, despite its current weaknesses and issues. A proper education of consumers would increased attention to health issues. The current trend which is gaining importance, that of health and well-being, is likely to increase and give the market a boost in coming years. Also, economic growth and an increase in the budgetary expenditure for health would represent a growth engine for this market.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Romania with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Romania, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Romania for free:

The Consumer Health in Romania market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Romania?
  • What are the major brands in Romania?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Romania - Industry Overview

EXECUTIVE SUMMARY

The market grows in 2011, more in value than in volume

Hospital expenses reach around 13% of the total market, while the retail covers the rest

Expenses for health remain among slowest in Europe

Chemists and pharmacies lead distribution

Market has good growth potential

KEY TRENDS AND DEVELOPMENTS

Clawback tax could have strong impact on market

General health and wellness trend likely to have positive effect

Demographic factor likely to encourage growth

Pharmaceutical channel increasingly concentrated

Market highly regulated and highly taxed

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC-Switches 2009-2011

SOURCES

  • Summary 2 Research Sources

Consumer Health in Romania - Company Profiles

Antibiotice SA in Consumer Health (Romania)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Antibiotice SA: Competitive Position 2011

Biofarm SA in Consumer Health (Romania)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Biofarm SA: Competitive Position 2011

Zentiva SA in Consumer Health (Romania)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 11 Zentiva SA: Competitive Position 2011

Adult Mouth Care in Romania - Category Analysis

HEADLINES

TRENDS

  • Self medication is increasingly used in adult mouth care, particularly since problems caused by unhealthy lifestyles, stress or bad eating habits are met more and more often. The most common problem is mouth ulcers and herpes, which are generally cured by Aciclovir (Gedeon Richter) and Zovirax (GlaxoSmithKline). These two products are equivalent in terms of both active substance and pricing, so the choice made by the consumer depends on the pharmacy stock and personal preference.

SWITCHES

COMPETITIVE LANDSCAPE

  • Domestic manufacturers dominated in 2011, due to lower prices and good availability. Furthermore, multinationals did not have a strong incentive to enter the category due to low product awareness and the strong semi-ethical component. Meduman Viseu and its brand Aftolizol led the segment due to the perception of the brand as the most appropriate for mouth ulcers.

PROSPECTS

  • The category is expected to see a CAGR of 1% over the forecast period, thanks to strong semi-ethical sales.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2006-2011
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 13 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 14 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Romania - Category Analysis

HEADLINES

TRENDS

  • Consumers continued to ask for generic products rather than branded analgesics or products from a specific manufacturer, which represents an advantage for local producers. Generics were much more popular in the established aspirin and acetaminophen categories, while branding was more important for imported offerings such as combination products, dipyrone and ibuprofen. The penetration of more expensive imported brands in the larger categories of aspirin, acetaminophen and combination products is a growing trend. It is particularly evident in the urban environment, but also depends a lot on pharmacists’ recommendations.

SWITCHES

COMPETITIVE LANDSCAPE

  • The analgesics category is dominated by domestic producers, which are in turn largely controlled by multinationals such as GlaxoSmithKline in the case of Europharm, Novartis with Lek Pharma Tech Romania, Sanofi-Aventis with Zentiva, or international companies such as Ranbaxy and Gedeon Richter. Smaller domestic companies such as Meduman Viseu, Magistra C & C SRL, AC Helcor, Pharmaplant Biogalenica, Remedia, Laropharm and Arena Group are active in analgesics, especially in acetaminophen and aspirin. Fabiol and Santa are partners with Ozone Laboratories in the production of analgesics.

PROSPECTS

  • Sales of analgesics are expected to grow over the forecast period, because the analgesics category already benefits from a strong level of self-medication and traditional consumption, which sees users purchasing cheaper, generic products.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2006-2011
  • Table 18 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 19 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 20 Analgesics Company Shares by Value 2007-2011
  • Table 21 Analgesics Brand Shares by Value 2008-2011
  • Table 22 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 23 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Romania - Category Analysis

HEADLINES

TRENDS

  • The level of self medication is pretty high, particularly in herb-based OTC products, as they are perceived as mostly non-harmful and with virtually no damaging side effects. Also, most non-herbal products are prescription-based only, not allowing self medication.

SWITCHES

COMPETITIVE LANDSCAPE

  • The category is split in two: herbal products, which are highly fragmented, and non-herbal, prescription products, where a few names are very familiar, such as Extraveral, Distonocalm (also UTC, produced by Sicomed) or Stilnox (UTC, produced by Lab Synthélabo).

PROSPECTS

  • The category has very good growth anticipated for the forecast period, with a constant value CAGR of 4%. This is because Romanians will continue to suffer from stress, anxiety and nervousness, and will want to treat these conditions with products that offer no side-effects. As such, the herbal content will continue to be the single criteria for the products to be classified as over-the-counter medicines. There is a certain trend of the EU to regulate herbal products and impose certain standards for such offerings, but currently they fit into the category of nutritional supplements and benefit from easier conditions for market presence.

CATEGORY DATA

  • Table 24 Sales of Calming and Sleeping: Value 2006-2011
  • Table 25 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 26 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 27 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 28 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 29 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Romania - Category Analysis

HEADLINES

TRENDS

  • This category is affected by seasonality, with higher sales registered in autumn and spring, when temperatures fluctuate and numerous allergens are present in the atmosphere, with lower sales in the winter months.

SWITCHES

COMPETITIVE LANDSCAPE

  • Multinationals strengthened their position in decongestants, cough remedies and pharyngeal preparations, which were the domain of domestic manufacturers for most of the review period, following the penetration of brands such as Strepsils, Septolete, Hexoral and Hexoraletten, to challenge the longstanding Faringosept pharyngeal preparations brand, and several brands with excellent positioning in cough remedies. However, as cough remedies experienced a lower level of self-medication, this led to increasing sales of foreign brands, recommended by pharmacists and popular due to advertising campaigns.

PROSPECTS

  • The constant value CAGR for this category over the forecast period is predicted to be 6%. Given the traditional use of cough and cold remedies, the level of self-medication is high, and this is expected to continue. As such, the category is expected to reach maturity in a few years. The dominance of domestic manufacturers with cheaper products is also expected to continue, contributing to a lower growth rate in value terms.

CATEGORY DATA

  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 32 Sales of Decongestants by Category: Value 2006-2011
  • Table 33 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 34 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 35 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 36 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 38 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Romania - Category Analysis

HEADLINES

TRENDS

  • In 2011 digestive remedies saw growth of 6%. Growth was relatively low as sometimes these products are replaced by more “traditional” methods of dealing with indigestion, particularly in rural areas, and also this category is reaching maturity.

SWITCHES

COMPETITIVE LANDSCAPE

  • The drugs manufactured by local producers dominated digestive remedies in 2011, with the top brands retaining the leading positions in the largest category of indigestion and heartburn remedies (Colebil/Bilichiol, Triferment). Biofarm, Zentiva and Europharm held important shares because the domestic brands benefit from recognition, traditional consumption and a higher level of self-medication. On the other hand, foreign brands are more expensive, and generally consumers need to have them recommended before purchasing them for the first time, as they are generally satisfied with Romanian-manufactured products.

PROSPECTS

  • The digestive remedies category is expected to register a 5% constant value CAGR over the forecast period. The trend is likely to move from alleviation to prevention, which is expected to be more aggressively targeted by manufacturers, with products advertised more intensively. Also, increasingly stressful lifestyles among consumers are likely to increase consumption, as the first affected is usually the digestive system. Furthermore, the eating habits of the Romanians are not very light, which represent a growth engine for digestive remedies.

CATEGORY DATA

  • Table 40 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 41 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 42 Digestive Remedies Company Shares by Value 2007-2011
  • Table 43 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 44 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 45 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Romania - Category Analysis

HEADLINES

TRENDS

  • The category remained underdeveloped at the end of the review period. This is easily explainable through the fact that the consumers are not so familiar with the products, and the category is rather limited, with only five to 10 products available in pharmacies, most being prescription-based.

SWITCHES

COMPETITIVE LANDSCAPE

  • In such a small category, with few products, the order of the main players remains rather constant. In 2011 Biofarm and Pharco led sales with value shares of 34% and 33%, respectively, followed by Pharmaplant with 30%.

PROSPECTS

  • Over the forecast period the ear care category is expected to see a constant value CAGR of around -4% to stand at just over RON4 million in 2016.

CATEGORY DATA

  • Table 46 Sales of Ear Care: Value 2006-2011
  • Table 47 Sales of Ear Care: % Value Growth 2006-2011
  • Table 48 Ear Care Company Shares by Value 2007-2011
  • Table 49 Ear Care Brand Shares by Value 2008-2011
  • Table 50 Forecast Sales of Ear Care: Value 2011-2016
  • Table 51 Forecast Sales of Ear Care: % Value Growth 2011-2016

Emergency Contraception in Romania - Category Analysis

TRENDS

  • Emergency contraception is currently being introduced in Romania, although it has achieved media attention since as early as 2001. For 2011 the category was negligible. The only such product found in pharmacies was the Escapelle pill, manufactured by Gedeon Richter and introduced in 2007, available on an OTC basis. In 2011 Postinor (also manufactured by Gedeon Richter) also appeared, but this product is not yet familiar to consumers.

Eye Care in Romania - Category Analysis

HEADLINES

TRENDS

  • Consumers are increasingly able to distinguish between various products and to buy some OTC products without prior medical consultation. This is particularly true of eye drops or ointments. An increasing number of people consider purchasing eye drops, particularly for tired eyes, not only for the treatment of specific health problems.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson has led this category for several years, with its top brand Visine – available in a multitude of varieties in 2011, accounting for a 41% value share.

PROSPECTS

  • The segment is seriously under-advertised and particularly in terms of OTC drugs, growth is stalled by this shortcoming.

CATEGORY DATA

  • Table 52 Sales of Eye Care by Category: Value 2006-2011
  • Table 53 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 54 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 55 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 56 Eye Care Company Shares by Value 2007-2011
  • Table 57 Eye Care Brand Shares by Value 2008-2011
  • Table 58 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 59 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Romania - Category Analysis

HEADLINES

TRENDS

  • For more than 30 years in Romania small outlets have sold herbal products called plafar. Moreover, in villages, beliefs and traditions are still strong, and traditional (“herbal”) remedies are very much trusted – not only by the rural population but also by some urban dwellers with roots in rural regions. Hence, herbal products are intrinsically trusted, and are also not believed to work miraculously. Herbal infusions, for example, are used very often for the treatment of minor colds, coughs and allergies, among other ailments, as well as plant extracts, mainly home-made.

COMPETITIVE LANDSCAPE

  • The category is rather fragmented and there are many unknown brands, but Krka Romania retained its leadership of herbal/traditional products in 2011, Laboratories Medica, Hofigal and Rotta Natura also excelled with regard to sales of herbal/traditional dietary supplements, while Laboratoarele Fares Biovital was an important player in herbal/traditional medicinal teas at the end of the review period. The products from such companies are available in chemists/pharmacies, as well as via Internet retailing and large grocery retailers.

PROSPECTS

  • Increasing consumer purchasing power is expected to lead to significant changes in consumption habits and lifestyle, which will in turn lead to growing demand for more sophisticated herbal products. Growth will be supported by increasing consumer health awareness and rising demand for natural products which alleviate minor problems. As such, the category is expected to see a constant value CAGR of 11% over the forecast period.

CATEGORY DATA

  • Table 60 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 61 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 62 Herbal/Traditional Products Company Shares 2007-2011
  • Table 63 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 64 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 65 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Romania - Category Analysis

HEADLINES

TRENDS

  • The highest share of sales in this category is held by lotion and cream/ointment acne treatments (over 90%). Pad and stick/wand products remained negligible, as they represented a new concept and Romanians continued to be conservative in terms of product formats. Meanwhile, while acne sufferers in the smaller cities and villages often tend to neglect acne unless it is very bad, when they generally seek a medical recommendation, the level of self-medication increased rapidly in Bucharest and other large cities. In such locations acne treatments target teenagers, which represents a more promising consumer group, but also adults with skin problems.

SWITCHES

COMPETITIVE LANDSCAPE

  • Antibiotice remained the leader in medicated skin care in 2011 with an 18% value share, followed by Novartis Consumer Health, with 12%. Antibiotice led in topical antifungals and topical germicidals/antiseptics, as well as holding strong positions in haemorrhoid treatments, vaginal antifungals, acne treatments, antipruritics and antiparasitics/lice (head and body) treatments.

PROSPECTS

  • Medicated skin care is expected to increase its share of the market by the end of the forecast period. Being almost exclusively distributed through pharmacies, the image of products in this category is of very good offerings with good curative properties, particularly when targeted to treat a specific problem. These products are also perceived as being very good value for money, although most are in the premium price segment

CATEGORY DATA

  • Table 66 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 67 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 68 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 69 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 70 Hair Loss Treatments Brand Shares by Value 2008-2011
  • Table 71 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 72 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Romania - Category Analysis

HEADLINES

TRENDS

  • Statistics show that Romania ranks fourth in Europe for the highest number of smokers. In 2011 around 35% of the population above 15 years of age smoked tobacco, equating to almost six million smokers in Romania. In fact, most Romanian smokers begin to smoke at 15 years of age or even younger. The fact that smoking in restaurants and clubs is still allowed encourages people to keep smoking, despite numerous anti-tobacco campaigns.

SWITCHES

COMPETITIVE LANDSCAPE

  • Nicorette by Johnson & Johnson is still the only over-the-counter brand present in NRT smoking cessation aids, available in gum and patch formats, and accounting for the vast majority of sales. The only competition for Johnson & Johnson came from domestic and international producers of herbal smoking cessation aids and prescription products.

PROSPECTS

  • Despite the fact that almost everywhere in the European Union smoking is prohibited in bars and restaurants (except for summer time and terraces), in Romania, due to the high number of smokers and to reduce a negative effect on sales, most locations allow smoking or allocate separate smoker/non-smoker areas. This situation is not expected to change in future.

CATEGORY INDICATORS

  • Table 73 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 74 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 75 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 76 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 77 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 78 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 79 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 80 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Romania - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition is a very new category to Romania, and most products are sold through gyms and sports clubs. Pharmacies started to introduce items from this category only recently, and mostly they are protein shakes and some amino acids. Joint and bone supplements are not sold as sport products but as products for elderly consumers or those with joint problems.

COMPETITIVE LANDSCAPE

  • The category is very fragmented. Nutrition companies target young body builders, but these consumers tend to prefer professional body-building products such as those manufactured by Met-Rx, Weider or Gaspari Nutrition.

PROSPECTS

  • This category is expected to remain rather niche, and will only appeal to consumers who are preoccupied with their body and its development via sports, and only marginal interest from those who want to lose weight.

CATEGORY DATA

  • Table 81 Sales of Sports Nutrition: Value 2006-2011
  • Table 82 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 83 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 84 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Romania - Category Analysis

HEADLINES

TRENDS

  • This category is becoming stronger, due to increasing concerns regarding health and lifestyles, which includes healthy eating, protecting the body, supplementing its needs and deficiencies and compensating for the shortcomings of a stressful urban environment with vitamins and dietary supplements.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Europharm, globally owned by GlaxoSmithKline, maintained its leading position in vitamins and dietary supplements in 2011, accounting for a 14% value share. The company maintained its leading position with the Eurovita brand due to its nationwide distribution network, warehouses, heavy advertising and diversified product range, as well as trust in its products and good image.

PROSPECTS

  • The media and educational campaigns have led to increasing consumer health awareness, which will in turn lead to more regular consumption of products such as vitamins and dietary supplements. Growth will be further stimulated by simplification of the registration process, the expansion of sales within chemist/pharmacy chains, and on-going modernisation of independent parapharmacies/drugstores. The forecast growth of vitamins and dietary supplements will also be fuelled by consequent changes in consumer lifestyles.

CATEGORY DATA

  • Summary 12 Dietary Supplements: Brand Ranking by Positioning 2011
  • Table 85 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 86 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 87 Dietary Supplements by Positioning 2006-2011
  • Table 88 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 89 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 90 Vitamins Brand Shares by Value 2008-2011
  • Table 91 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 92 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 93 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Romania - Category Analysis

HEADLINES

TRENDS

  • More than two-thirds of sales come from weight loss supplements, which were worth RON31 million in 2011. Products in this category are often recommended by specialists as they are perceived by many consumers as requiring specialist advice prior to use. By contrast, medical advice continues to be frequently neglected by people when starting a diet, and the main sources of dieting information remains word-of-mouth, and more recently the media, magazines and the Internet.

COMPETITIVE LANDSCAPE

  • Walmark maintained its leading position in 2011, accounting for a 31% value share, with its brands Viaredin, Clarinol and Cromdiet. Plantextrakt ranked second with 6%. Laboratoarele Fares Biovital ranked fifth, with the majority of sales being generated by its Fares slimming teas brand. The decline in share of Herbalife’s sales, due mainly to a high unit price, led to the importance of direct selling within the category declining significantly.

PROSPECTS

  • The entire category is expected to see a good performance and development over the forecast period. Weight loss supplements will continue to drive growth in the slimming products category over the forecast period. Such products are often perceived as being the most efficient slimming products available thanks to their perceived lack of side effects.

CATEGORY DATA

  • Table 94 Sales of Weight Management: Value 2006-2011
  • Table 95 Sales of Weight Management: % Value Growth 2006-2011
  • Table 96 Weight Management Company Shares 2007-2011
  • Table 97 Weight Management Brand Shares 2008-2011
  • Table 98 Forecast Sales of Weight Management: Value 2011-2016
  • Table 99 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Romania - Category Analysis

HEADLINES

TRENDS

  • Value growth in 2010 stemmed from the improved quality of wound treatments and unit price increases, supported by rising household incomes. Sticking plasters are among the few consumer healthcare products which have a strong presence in large grocery outlets. Expansion of supermarkets/hypermarkets also contributed to this performance, although such products are sold through almost all retail channels and available almost everywhere, from outdoor markets to pharmacies.

COMPETITIVE LANDSCAPE

  • Romanian company Mebra SRL remained the best performer in 2011 with a 10% value share, while Laboratoires URGO came strongly from behind with 8%, offering a very wide variety of products.

PROSPECTS

  • The category is expected to see a 3% constant value CAGR over the forecast period. Sticking plasters will continue to be the most dynamic category due to the introduction of improved features and increased availability in both urban and rural areas.

CATEGORY DATA

  • Table 100 Sales of Wound Care by Category: Value 2006-2011
  • Table 101 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 102 Wound Care Company Shares by Value 2007-2011
  • Table 103 Wound Care Brand Shares by Value 2008-2011
  • Table 104 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 105 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Guarana
            • Microalgae
            • Sea Buckthorn
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Lecithin
            • Propolis
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Paediatric Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Paediatric Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Paediatric Consumer Health
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Diclofenac
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Ketoprofen
        • Paediatric Naproxen
      • Paediatric Cough, Cold and Allergy Remedies
        • Paediatric Allergy Remedies
        • Paediatric Cough/Cold Remedies
      • Paediatric Digestive Remedies
        • Paediatric Diarrhoeal Remedies
        • Paediatric Indigestion and Heartburn Remedies
        • Paediatric Laxatives
        • Paediatric Motion Sickness Remedies
      • Paediatric Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Paediatric Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!